NCT04938609 2026-04-09
Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (NIRT 2-HNC)
Providence Health & Services
Phase 2 Active not recruiting
Providence Health & Services
RTOG Foundation, Inc.
Groupe Oncologie Radiotherapie Tete et Cou
National Cancer Institute (NCI)